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Abstract
To determine the spatial and temporal dynamics of influenza A virus during a single epidemic, we examined whole-genome
sequences of 284 A/H1N1 and 69 A/H3N2 viruses collected across the continental United States during the 2006–2007
influenza season, representing the largest study of its kind undertaken to date. A phylogenetic analysis revealed that
multiple clades of both A/H1N1 and A/H3N2 entered and co-circulated in the United States during this season, even in
localities that are distant from major metropolitan areas, and with no clear pattern of spatial spread. In addition, co-
circulating clades of the same subtype exchanged genome segments through reassortment, producing both a minor clade
of A/H3N2 viruses that appears to have re-acquired sensitivity to the adamantane class of antiviral drugs, as well as a likely
antigenically distinct A/H1N1 clade that became globally dominant following this season. Overall, the co-circulation of
multiple viral clades during the 2006–2007 epidemic season revealed patterns of spatial spread that are far more complex
than observed previously, and suggests a major role for both migration and reassortment in shaping the epidemiological
dynamics of human influenza A virus.
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Introduction
Intensive study of the molecular evolution of influenza A virus
has provided important insights into its seasonal genesis and
spread in human populations [1–4]. The rapidity with which both
epidemics and pandemics of influenza A virus arise and spread
globally has also generated great interest in understanding the
spatial-temporal dynamics of this important human pathogen [5–
9]. Phylogenetic trees of the epitope-rich HA1 domain of subtype
H3N2 influenza A viruses sampled since its emergence in 1968
exhibit a distinctive ‘cactus-like’ pattern, in which most lineages go
extinct within a few years of their genesis, so that usually only a
single lineage persists between seasonal epidemics [10,11]. This is
most likely the result of strong host-mediated selection pressure,
resulting in continual evolution at key antigenic sites, a process
termed ‘antigenic drift’ [11,12]. This antigenic evolution is also
episodic, with major changes in antigenicity occurring with a
periodicity of approximately 3 years [13]. A variety of epidemi-
ological and evolutionary models have been developed to explain
this phylogenetic pattern [14,15], and how the evolution of the
HA1 domain relates to that in the rest of the viral genome [16].
Although antigenic drift is clearly a key determinant of influenza
A virus evolution, this process has rarely been observed in a single
locality over a single epidemic season [17,18]. Rather, multiple
viral introductions appear to drive evolution at the scale of local
epidemics, allowing for the co-circulation of multiple clades of the
same subtype [16,18]. At a global scale, viral migration from
regions characterized by more persistent influenza transmission,
notably East and South-East Asia, appears to be important in
determining large-scale epidemiological patterns [19,20,21]. In
addition, reassortment events between viruses of the same subtype
occur frequently, and are sometimes associated with major
antigenic changes in both the A/H3N2 [22] and A/H1N1
subtypes [23]. However, a complete understanding of the
evolutionary and epidemiologic dynamics of influenza A virus at
all spatial and temporal scales remains an important goal [24].
Every winter, epidemics of human influenza recur in the United
States, and are associated with an annual average of 226,000
hospitalizations and 36,000 deaths, mainly caused by secondary
bacterial pneumonia in the elderly and young children [25,26].
Epidemiological models have found a strong correlation between
the regional spread of influenza virus infection in the United States
and the movement of people to and from their workplace [9]. In
addition, US influenza epidemics tend to originate in California,
which may reflect this region’s interconnectivity to Asia and
Australia [9]. Although of great importance, most spatial models
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I) and hence do not consider the evolutionary history of the viruses
involved. Indeed, it is striking that detailed phylogenetic analyses
of influenza A viruses from a single season at a national level have
not been undertaken, even though the rapid rate of influenza A
virus evolution [14,27–29] means that viral genome sequences
may contain important information on country-wide spatial
dynamics.
Our goal here is to determine the spatial-temporal dynamics of
influenza A virus during a single epidemic season (2006-2007) in
the United States through the phylogenetic analysis of whole-
genome sequence data. Since the 1968 pandemic, A/H3N2
viruses typically dominate most influenza seasons, including 16 of
the past 20 US epidemics ([30], for example), and are associated
with higher levels of morbidity and mortality [31], higher rates of
evolutionary change [14], and greater synchrony in the timing of
local epidemics across the United States than A/H1N1 viruses [9].
However, during the 2006–2007 US influenza epidemic, more
viruses reported by the CDC were of the A/H1N1 (62.3%) than
the A/H3N2 subtype (37.7%) [30]. The evolutionary dynamics of
this epidemic were particularly complex, including a late-season
switch in dominance from the A/H1N1 to the A/H3N2 subtype,
the co-circulation of multiple antigenically distinct lineages within
both A/H1N1 and A/H3N2, an A/H3N2 vaccine mismatch, and
the co-circulation of adamantane resistant and sensitive viral
lineages in both subtypes [30,32]. Our analysis of 353 whole-
genome influenza A virus sequences of both the A/H1N1
(n=284) and A/H3N2 (n=69) subtypes from this 2006–2007
US season represents the first attempt to investigate the spatial-
temporal spread of a nationwide influenza virus epidemic within
the context of genomic-scale evolutionary dynamics.
Results
Multiple introductions of A/H1N1 influenza virus during
the 2006–2007 US season generate complex spatial
patterns
Our phylogenetic analysis of 284 whole-genome A/H1N1
influenza viruses sampled between December 2006 and March
2007 in 17 US states revealed substantial genetic diversity for all
eight segments of the viral genome. In particular, eight
phylogenetically distinct clades (denoted A–H), defined by both
high bootstrap values and long branch lengths, are evident on the
trees of each genome segment, as exemplified by the HA
phylogeny (Figure 1). The phylogenies of the seven other genome
segments contain clades identical to those on the HA phylogeny
(Figures S1, S2, S3, S4, S5, and S6, with the PB1 phylogeny
presented in Figure 2). Previous studies [20,22–23] suggest that
each clade is likely to represent a separate introduction of the virus
into the United States, although the small sample of sequences
available mean that individual clades may sometimes represent
multiple introduction events. One clade, herein denoted clade A,
was clearly dominant, as it comprised the majority of isolates (175/
284 isolates, 61.6%, Table 1). Minor clades B, C, D, E, F, G, and
H contained only 47, 12, 35, 6, 6, 1, and 2 isolates each,
respectively (Table 1).
Clade A was the most geographically and temporally pervasive
of the eight clades, circulating in 24/30 localities and 14/15 weeks
studied, although allowall clades were sampled over wide temporal
and geographic scales (Table 1, Figures 3, 4). Notably, there was
no association between the phylogenetic positions of isolates and
their week of collection (Figure 3) or geographic region (Figure 4).
Rather, clades co-circulated in both time and space, with small
clades that are detected in only a single region (E, G, and H) to
likely be an artifact of limited sampling. The largest clades A and B
were highly geographically dispersed, containing isolates collected
from both relatively isolated areas and major US cities spanning all
six US regions, including 24 and 18 out of 30 localities sampled,
respectively (Table 1, Figure 4). However, in contrast to a
simplified spatial model in which a single lineage spreads in a
unidirectional manner, we observed no strong signal for viral
migration among the co-circulating clades, even when individual
clades were studied in isolation (Table 2). Indeed, a parsimony-
based analysis in which the US state of origin of each isolate is
coded as an extra character and mapped onto each ML tree
revealed a strong clustering by US state (p,0.001), but only weak
evidence for movement among states (data not shown; available
from the authors on request).
The number of isolates collected from different US localities
varied widely (ranging from 1 isolate from Detroit, Michigan to 42
isolates from Houston, Texas, Table 1), and such geographical
biases in our data had a profound effect on spatial patterning.
Accordingly, the number of clades identified in a locality was
strongly associated with the number of isolates sampled from that
locality (Spearman rho=0.77, P,0.0001), while the population
size of each locality was not associated with the number of viruses
or clades identified (P.0.69). In addition, the first virus isolated in
our A/H1N1 sample was from Cincinnati, Ohio (Table 2), likely
an artifact of the relatively large sample collected from this city (30
isolates, Table 1).
The peak in A/H1N1 genetic diversity occurred during early
February (corresponding to week 10, Table 2), with six of the eight
clades co-circulating during this week. Geographically uneven
sampling also meant that the most clades were detected in the
most heavily sampled localities. For example, six clades (A, B, C,
D, E, and F) were detected in Houston, Texas, the most intensively
sampled locality (Table 1). Extensive genetic diversity was also
detected within a single week: as a case in point, at least four clades
(A, B, D, F), representing two major antigenically distinct lineages
circulating globally (see below), were all present in Houston, Texas
during week 10 (Table 2). Abundant viral diversity was also
detected in localities that contributed relatively few (6–14) isolates,
including both urban and remote areas. Three different clades
circulated in all of the following localities: Los Angeles, California
(clades A, C, F); Denver, Colorado (clades A, C, G); New York
Author Summary
This study is the first of its kind to reconstruct the spread
of an epidemic of influenza A virus across a single country,
in this case the United States. In contrast to a single viral
lineage spreading across this country, a phylogenetic
analysis of the whole-genome sequences of more than 300
influenza A viruses of the A/H1N1 and A/H3N2 subtypes
sampled from the 2006–2007 epidemic season reveals that
multiple phenotypically and antigenically distinct viral
lineages of entered and co-circulated in the US during this
time. Furthermore, the widespread co-circulation of
multiple lineages, even in geographically remote localities,
allowed for frequent reassortment between influenza A
viruses of the same subtype. Through reassortment, a
minor lineage of A/H3N2 viruses surprisingly re-acquired
sensitivity to the adamantane class of antiviral drugs, and a
new A/H1N1 antigenic variant emerged that later became
globally dominant. In sum, these results highlight the
complexity of the spread of influenza A virus in time and
space, and highlight the need for intensified global
surveillance involving whole-genome sequence data.
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B, D), Aberdeen, Mississippi (clades A, D, F); and Weber City,
Virginia (clades A, B, D) (Table 2). In fact, more than one clade
was observed in every locality from which .1 viral sample was
obtained (Table 2).
At least three antigenically distinct clades of A/H1N1
virus co-circulated
To view the phylogenetic relationships among A/H1N1 clades
from the 2006–2007 epidemic in a wider geographical context, we
included 48 background A/H1N1 influenza viruses sampled from
the northern and southern hemispheres between 2001–2006, years
that were dominated by viruses antigenically similar to A/New
Caledonia/20/1999 (‘New Caledonia-like’) [30]. These sequences
were available for the HA and NA segments, including three
antigenically distinct influenza vaccine reference strains selected
for 2006–2007 (A/New Caledonia/20/1999), 2007–2008 (A/
Solomon Islands/3/2006), and 2008–2009 (A/Brisbane/59/2007)
(Figure 1) [30,33,34]. Of the eight clades that co-circulated during
the 2006–2007 season, five (A, B, C, D, and E) appear to be
descendents of New Caledonia-like viruses from 2002–2005,
(Figure 1), while three (F, G, H) are separated from all other
isolates by a very long branch with high (100%) bootstrap support
(Figure 1). Due to their extensive phylogenetic divergence, we
define clades F, G, and H as ‘set 2’ clades, in contrast to the ‘set 1’
clades A, B, C, D, and E.
We inferred the antigenic characteristics of these eight clades
based on their phylogenetic relationships and the number of
amino acid differences at antigenic sites in the HA from vaccine
reference strains of known antigenicity. Accordingly, set 1 clades
A, B, C, D, and E are likely to be New Caledonia-like in
antigenicity, given that (a) 90% of A/H1N1 viruses from this US
epidemic were New Caledonia-like (as characterized by the CDC
surveillance [30]) and set 1 clades were most prevalent, (b) set 1
clades are phylogenetically related to other New Caledonia-like
viruses from 2002–2005 (Figure 1), and (c) set 1 clades differ by
only 3–5 amino acids from A/New Caledonia/20/1999, 1–2 of
which occurred in antigenic or potential glycosylation sites, versus
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Figure 1. Phylogenetic relationships of the HA gene segment of 100 A/H1N1 influenza viruses sub-sampled from all eight clades
that co-circulated in the United States during the 2006–2007 influenza season, 67 global isolates from 2001–2006, and the A/H1N1
component of the influenza vaccine used from the years 2000–2001 to 2006–2007 (A/New Caledonia/20/1999), the A/H1N1 strain
selected for the 2007–2008 vaccine (A/Solomon Islands/3/2006), and the 2008–2009 A/H1N1 vaccine component, (A/Brisbane/59/
2007), estimated using an ML method. Colored rectangles (labeled A–H) represent eight clades of related viral isolates from the 2006–2007 US
season that are present on phylogenies for all eight viral genome segments (Figures S1, S2, S3, S4, S5, S6). Global background isolates are unshaded
and labeled by season in red font. Vaccine strains are highlighted in olive green. Bootstrap values (.70%) are shown for key nodes. The tree is mid-
point rooted for purposes of clarity only, and all horizontal branch lengths are drawn to scale.
doi:10.1371/journal.ppat.1000133.g001
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Table 3). It is possible that clades C and D represent additional
antigenic variants of New Caledonia-like viruses, given the higher
number of amino acid changes in antigenic sites (2) also observed
in these viruses (Figure 5). However, given the uncertainties
involved in inferring antigenic properties from genetic data alone,
our antigenic assignments should not be considered definitive.
In contrast, set 2 clades F, G, and H appear to be related to two
emerging antigenic variants. Clade H may be antigenically similar
to the A/Solomon Islands/3/2006 vaccine strain selected for
2007–2008, based on their close phylogenetic relationship
(Figure 1) and the low number of amino acid differences in
antigenic sites (1 site, Table 3). Clade F is more phylogenetically
related to the A/Brisbane/59/2007 2008–2009 vaccine strain,
and there are no differences at antigenic sites in these viruses.
Clades F and G differ by nine amino acids in the HA, but only one
difference occurs at an antigenic site, suggesting that, although
phylogenetically distinct, clade G may also be A/Brisbane/59/
2007-like in antigenicity.
Also of note was the observation that of the 284 A/H1N1
influenza viruses sequenced in this study, only one isolate–A/
Colorado/UR06-0053/2007–the sole member of clade G,
contained the S31N amino acid replacement in the M2 protein
that is associated with resistance to the adamantane class of
antivirals (Table 4) [35].
Clade F was generated by intra-subtype reassortment
between antigenic variants
Although clade F was classified as a member of clade set 2 due
to the phylogenetic relatedness of its HA gene segment to clades G
and H, this clade in fact appears to be set 1-set 2 reassortant.
Specifically, on trees inferred for the PB2, PA, HA, and NA
segments, clade F isolates are related to Solomon Islands-like set 2
clades G and H (as exemplified by the phylogeny of the HA gene
segment, Figure 1). However, clade F is more closely related (with
high bootstrap support) to the New Caledonia-like set 1 clades of
A, B, C, and D in segments PB1, NP, M, and NS (as exemplified
by phylogeny of PB1 gene segment, Figure 2; see Figures S1, S2,
S3, S4, S5, and S6 for phylogenies of other segments). As half of
the genome (PB1, NP, M, and NS) of these reassortant viruses was
acquired from set 1-like viruses that began circulating in 2005, this
reassortment event most likely occurred between 2005–2006.
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Figure 2. Phylogenetic relationships of the PB1 gene segment of 100 A/H1N1 influenza viruses sampled from the US during the
2006–2007 influenza season and 48 globally from 2001–2006, estimated using an ML method (representative of phylogenies for
NP, M1/2, and NS1/2). Labels, shading, and rooting are the same as for Figure 1. Arrow indicates reassortant clade F.
doi:10.1371/journal.ppat.1000133.g002
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resistant A/H3N2 influenza viruses co-circulated during
the 2006–2007 US epidemic
Although fewer A/H3N2 influenza viruses (n=69) were
available for study due to the dominance of the A/H1N1 subtype
during the 2006–2007 season, abundant genetic diversity is
evident on all eight segment phylogenies, as exemplified by the
HA tree (Figure 6; see Figures 7–9 and Figures S7, S8, S9, and S10
for trees of remaining segments). To obtain greater resolution, we
also estimated phylogenetic trees that included 104 whole genome
A/H3N2 influenza viruses sampled globally from 2003–2006 [36],
as well as the HA and NA sequences from the A/H3N2
components of influenza vaccines selected for the 2006–2007/
2007–2008 (A/Wisconsin/67/2005) and 2008–2009 (A/Bris-
bane/10/2007) seasons [30,33,34].
The majority (60/69, 87.0%) of the A/H3N2 isolates from the
2006–2007 US epidemic were members of a major clade (denoted
clade ‘a’). On both the HA and NA phylogenies, clade a contains
the antigenically novel A/Brisbane/10/2007 isolate selected for
the 2008–2009 vaccine, whereas only three 2006–2007 singleton
isolates (i.e. isolates that were phylogenetically isolated; described
below) belong to the clade that contains the 2006–2007 influenza
vaccine strain A/Wisconsin/67/2005, confirming prior observa-
tions of a vaccine mismatch (Figure 6) [30]. This A/Wisconsin/
67/2005-like clade first emerged in 2005 and represented a class of
viruses that were adamantane-resistant due to the S31N mutation
in M2; it was termed the ‘N-lineage’ in previous work [36]. This
N-lineage is closely related to some 2003 isolates (previously
termed ‘clade B’ [36]) in 4 of the 8 segment phylogenies (PB1, PA,
NP, and M) (Figures 7, 8, 9, Figure S8), confirming that a 4+4
reassortment event was responsible for the genesis of the N-lineage
[36]. As with the N-lineage, all isolates in clade a contained the
S31N mutation in M2 that confers adamantane resistance
(Figure 6).
In addition to the major clade a, a minor clade of five A/H3N2
viruses, denoted clade b, also circulated during the 2005–2006
Table 1. Number of A/H1N1 influenza viruses sampled per locality, per clade (Figure 1).
Pop* A B C D E F G H TOTAL
Major cities New York City, NY 8214 2 2 2 6
Los Angeles, CA 3849 5 7 2 14
Chicago, IL 2833 12 3 15
H o u s t o n , T X 2 1 4 4 2 318361 4 2
Mid-sized cities Detroit, MI 871 1 1
Denver, CO 567 8 1 1 10
Nashville, TN 552 1 1
Oklahoma City, OK 538 2 1 3
Portland, OR 537 6 6
Kansas City, MO 447 9 1 1 11
Cleveland, OH 444 1 1 2
Tampa, FL 333 8 4 12
Cincinnati, OH 332 23 2 4 1 30
Toledo, OH 298 1 1
Birmingham, AL 229 1 1
Akron, OH 210 1 1
Winston-Salem, NC 197 1 1
Richmond, VA 193 13 1 14
Knoxville, TN 182 9 2 11
Minor cities/town Albany, NY 94 12 2 14
Madison, AL 36.8 1 1
Pekin, IL 33.4 2 9 11
Hopkinsville, KY 30.1 15 7 4 26
Tullahoma, TN 18.9 1 2 8 11
Dyersburg, TN 17.4 1 1 2
Washington, OH 13.5 9 3 12
Graham, NC 12.8 2 1 3
Aberdeen, MS 6.4 9 1 1 14
Weber City, VA 1.3 6 3 1 7
Dunlap, IL 0.9 1 1
TOTAL 175 47 12 35 6 6 1 2 284
Localities are listed in order of population size (
*per 1,000 persons) and categorized as major cities (population of .1 million), mid-sized cities (population size of
100,000–999,999), or minor cities/towns (population of ,99,999). Total number of isolates per locality listed in far right column.
doi:10.1371/journal.ppat.1000133.t001
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adamantane resistant N-lineage, every isolate in clade b contains
the adamantane-sensitive serine (S) at position 31 of the M2,
indicating that a reversion has occurred. In addition, clades a and
b may vary antigenically, as they differ in numerous amino acids in
HA, five of which occur in antigenic sites A, B, and C (amino acid
sites 50, 140, 142, 157, 173) and one–site 142–in the HA1 domain
that was previously identified as undergoing positive selection [37].
Four singleton A/H3N2 viruses (labeled s1, s2, s3, and s4) also
circulated during this season (Figure 6). Isolates s1, s2, and s3 are
members of the older N-lineage and possess the associated
adamantane-resistance S31N mutation. In contrast, isolate s4 is
adamantane sensitive and clusters with other adamantane sensitive
isolates, including clade b. The HA of isolate s4 differs from that of
the major clade a by 12 amino acids, 8 of which occur at antigenic
sites and 2 at previously identified positively selected sites (amino
acid sites 193 and 275) [37] (Table 5). Similarly, the HA of s4
differs from clade b by 12 amino acids, 7 of which occur at
antigenic sites and 2 at positively selected sites (142 and 193). In
contrast, the HA of isolates s1, s2, and s3 differs from clade a by
only 6, 2, and 4 amino acids in 3, 1, and 2 antigenic sites,
respectively. In sum, as many as four antigenic variants of A/
H3N2 influenza virus may have co-circulated this season (although
this will be to be confirmed experimentally), each of which is likely
to represent a separate introduction event: A/Wisconsin/67/
2005-like (isolates s1, s2, and s3), A/Brisbane/10/2007-like (major
clade a), clade b, and isolate s4 (Table 4).
Multiple reassortment events involving A/H3N2 influenza
viruses from the 2006–2007 US epidemic
Major topological differences between the eight phylogenies of
the A/H3N2 virus genome strongly suggest that several reassort-
ment events took place involving multiple clades from the 2006–
2007 US epidemic. Whereas the adamantane-resistant clade a and
the sensitive clade b both appear to derive from the N-lineage on
the trees for the PB2, PA, HA, NA and NS segments, clade b
instead derives from the adamantane sensitive clades from 2004–
2005 on the M and PB1 trees (Figures 7, 8). This major
phylogenetic incongruity strongly suggests that clade b viruses re-
acquired sensitivity to adamantane by acquiring an older
adamantane-sensitive M segment (with a serine at site 31 of the
M2 gene) through reassortment. The NP segment also has
undergone a major reassortment event, as on the NP phylogeny
both clades a and b descend from adamantane sensitive clades,
rather than from the N-lineage (Figure 9). The varying
phylogenetic positions of the s4 isolate across the genome also
suggest that this singleton virus resulted from multi-segment
reassortment (Figures 6–9, Figures S7, S8, S9, S10). The s4 isolate
is closely related to clade b on phylogenies of the PB2, PB1, NP,
M, and NS segments (having reassorted along with clade b in the
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Figure 3. Temporal patterning of isolates contained in eight clades of A/H1N1 influenza viruses identified in Figure 1. Colored
rectangles contain individual isolates that were collected during the week associated with that color (see Color Key). Dates for weeks 1–15 are the
same as those used in Table 2. Branches leading to background isolates have been removed for clarity.
doi:10.1371/journal.ppat.1000133.g003
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contrast, on phylogenies of the PA, HA, and NA segments this
virus is divergent from all other clades (Figure 6, Figures S7, S8,
S9, S10).
Spatial dynamics of A/H3N2 influenza viruses
No clear signal of the geographical spread of A/H3N2 influenza
viruses could be detected due to our small sample size. All clades
were geographically widespread and a secondary parsimony
character mapping analysis again revealed strong population
subdivision and weak migration (results not shown; available from
authors upon request). The major clade a was present in all
thirteen localities in which A/H3N2 viruses were collected, and
the five isolates contained in minor clade b were geographically
dispersed across both urban and remote areas spanning four of five
US regions: Los Angeles, California; Chicago, Illinois; Hopkins-
ville, Kentucky; Madison, Alabama; New York City, New York;
and Houston, Texas (Table 2). New York City exhibited the most
A/H3N2 diversity, as major clade a, minor clade b, and singleton
viruses s3 and s4 all were detected, which is remarkable given that
only six total A/H3N2 isolates were collected from this locality
(Table 2). In some cases, multiple clades of both A/H3N2 and A/
H1N1 viruses co-circulated over restricted spatial-temporal scales.
As a case in point, at least two A/H1N1 clades and two A/H3N2
clades circulated during week 12 in Chicago, Illinois, week 13 in
Houston, Texas, and week 14 in Los Angeles, California (Table 2).
Considering both A/H1N1 and A/H3N2 isolates together, large
amounts of genetic diversity circulated in both urban and remote
areas of the US: a total of 8 clades of influenza A virus circulated
in Houston, Texas during the epidemic, 7 in New York City, New
York, 6 in Los Angeles, California, and 5 clades each in Denver,
Colorado, Cincinnati, Ohio, and Hopkinsville, Kentucky (Table 2).
Discussion
This study utilized whole-genome sequence data from a
surveillance initiative of unprecedented scope and scale that
sampled both A/H1N1 and A/H3N2 influenza viruses across the
US over the course of a single season through the Influenza
Genomics Sequencing Project [38]. Rather than a single viral
lineage spreading across the US, multiple lineages of both A/
H3N2 and A/H1N1 influenza virus were separately introduced
and co-circulated, allowing for reassortment within subtypes and
greatly complicating patterns of spatial-temporal spread. Given the
extent of genetic diversity observed during this season, obtaining a
strong signal for the spatial-temporal pattern of spread of multiple
different lineages clearly would entail a large increase in sampling.
A/Texas/UR06-0026/2007(H1N1)
A/Texas/UR06-0420/2007(H1N1) A/Texas/UR06-0467/2007(H1N1)
A/Texas/UR06-0468/2007(H1N1)
A/Texas/UR06-0503/2007(H1N1)
A/Texas/UR06-0542/2007(H1N1)
A/Florida/UR06-0208/2007(H1N1)
A/Vermont/UR06-0301/2007(H1N1)
A/Florida/UR06-0501/2007(H1N1)
A/Oregon/UR06-0186/2007(H1N1)
A/Texas/UR06-0012/2006(H1N1) A/Kansas/UR06-0085/2007(H1N1)
A/Kentucky/UR06-0425/2007(H1N1)
A/Mississippi/UR06-0047/2007(H1N1)
A/Tennessee/UR06-0119/2007(H1N1)
A/Texas/UR06-0157/2007(H1N1)
A/Virginia/UR06-0332/2007(H1N1)
A/Oklahoma/UR06-0063/2007(H1N1)
A/Illinois/UR06-0146/2007(H1N1)
A/Tennessee/UR06-0080/2007(H1N1)
A/Tennessee/UR06-0277/2007(H1N1) A/California/UR06-0125/2007(H1N1)
A/California/UR06-0232/2007(H1N1)
A/New York/UR06-0386/2007(H1N1)
A/California/UR06-0585/2007(H1N1)
A/Colorado/UR06-0499/2007(H1N1)
A/Kansas/UR06-0191/2007(H1N1)
A/Kentucky/UR06-0042/2007(H1N1)
A/Kentucky/UR06-0161/2007(H1N1)
A/Michigan/UR06-0015/2006(H1N1)
A/Ohio/UR06-0177/2007(H1N1) A/Illinois/UR06-0074/2007(H1N1)
A/Illinois/UR06-0491/2007(H1N1)
A/Kentucky/UR06-0028/2007(H1N1)
A/New York/UR06-0253/2007(H1N1)
A/North Carolina/UR06-0011/2006(H1N1)
A/North Carolina/UR06-0099/2007(H1N1)
A/Virginia/UR06-0254/2007(H1N1)
A/Ohio/UR06-0429/2007(H1N1)
A/Tennessee/UR06-0262/2007(H1N1)
A/Kentucky/UR06-0057/2007(H1N1) A/Kentucky/UR06-0363/2007(H1N1)
A/Texas/UR06-0398/2007(H1N1)
A/Texas/UR06-0133/2007(H1N1)
A/Texas/UR06-0195/2007(H1N1)
A/Texas/UR06-0306/2007(H1N1)
A/Florida/UR06-0049/2007(H1N1)
A/Florida/UR06-0577/2007(H1N1)
A/Vermont/UR06-0050/2007(H1N1)
A/Vermont/UR06-0485/2007(H1N1) A/Vermont/UR06-0511/2007(H1N1)
A/Vermont/UR06-0576/2007(H1N1)
A/Kansas/UR06-0143/2007(H1N1)
A/Colorado/UR06-0498/2007(H1N1)
A/Illinois/UR006-018/2007(H1N1)
A/Kansas/UR06-0192/2007(H1N1)
A/Kentucky/UR06-0128/2007(H1N1)
A/Kentucky/UR06-0328/2007(H1N1)
A/Texas/UR06-0039/2007(H1N1)
A/Vermont/UR06-0035/2007(H1N1) A/Virginia/UR06-0562/2007(H1N1)
A/Tennessee/UR06-0509/2007(H1N1)
A/Colorado/UR06-0110/2007(H1N1)
A/Illinois/UR06-0032/2007(H1N1)
A/Kentucky/UR06-0007/2006(H1N1)
A/Kentucky/UR06-0010/2006(H1N1)
A/Kentucky/UR06-0027/2007(H1N1)
A/Kentucky/UR06-0043/2007(H1N1)
A/Texas/UR06-0563/2007(H1N1)
A/Kentucky/UR06-0081/2007(H1N1) A/Kentucky/UR06-0220/2007(H1N1)
A/Ohio/UR06-0443/2007(H1N1)
A/Virginia/UR06-0594/2007(H1N1)
A/Mississippi/UR06-0048/2007(H1N1)
A/New York/UR06-0134/2007(H1N1)
A/Ohio/UR06-0522/2007(H1N1)
A/Texas/UR06-0025/2007(H1N1)
A/Texas/UR06-0204/2007(H1N1)
A/Texas/UR06-0380/2007(H1N1)
A/Texas/UR06-0582/2007(H1N1) A/Virginia/UR06-0075/2007(H1N1)
A/Virginia/UR06-0244/2007(H1N1)
A/Virginia/UR06-0387/2007(H1N1)
A/Alabama/UR06-0455/2007(H1N1)
A/Alabama/UR06-0536/2007(H1N1)
A/Mississippi/UR06-0014/2006(H1N1)
A/Mississippi/UR06-0145/2007(H1N1)
A/Tennessee/UR06-0151/2007(H1N1)
A/Virginia/UR06-0384/2007(H1N1) A/California/UR06-0321/2007(H1N1)
A/North Carolina/UR06-0364/2007(H1N1)
A/Kentucky/UR06-0476/2007(H1N1)
A/California/UR06-0393/2007(H1N1)
A/California/UR06-0479/2007(H1N1) A/Stockholm/23/06 H1N1
A/Mississippi/UR06-0378/2007(H1N1)
A/Tennessee/UR06-0045/2007(H1N1))
A/Texas/UR06-0217/2007(H1N1)
A/Colorado/UR06-0053/2007(H1N1)
A/New York/UR06-0199/2007(H1N1)
A/New York/UR06-0326/2007(H1N1)
A
B
C
D E
F G
H
2005
OREGON
MONTANA
WASHINGTON
WYOMING
NEVADA
ARIZONA
UTAH
COLORADO
NEW MEXICO
KANSAS
OKLAHOMA
MISSOURI
ARKANSAS
TEXAS
NORTH DAKOTA
SOUTH DAKOTA
NEBRASKA
MINNNESOTA
WISCONSIN
IOWA
ILLINOIS
INDIANA
MICHIGAN
MICHIGAN
FLORIDA
LOUISIANA
M
I
S
S
I
S
S
I
P
P
I
A
L
A
B
A
M
A
GEORGIA
SOUTH
CAROLINA
TENNESSEE
NORTH
CAROLINA
KENTUCKY
VIRGINIA
WEST
VIRGINIA
OHIO
PENNSYLVANIA
MARYLAND
DELAWARE
NEW JERSEY
CONNECTICUT
RHODE ISLAND
MASSACHUSETTS
MAINE
NEW
YORK
NEW HAMPSHIRE
VERMONT
ALASKA
CALIFORNIA
IDAHO
HAWAII
1
2
3
4
5
6
Figure 4. Spatial patterning of isolates contained in eight clades identified on the phylogeny of the HA gene segment of A/H1N1
influenza viruses from the 2006–2007 US epidemic that were identified in Figure 1. Colored rectangles contain individual isolates from the
region of the United States associated with that color (see colored map): region 1 (Northeast) is orange, region 2 (Mid-Atlantic) is red, region 3 (South)
is yellow, region 4 (Midwest) is green, region 5 (South Central) is blue, and region 6 (West) is purple. Branches leading to background isolates have
been removed for clarity.
doi:10.1371/journal.ppat.1000133.g004
Molecular Epidemiology of Influenza Virus
PLoS Pathogens | www.plospathogens.org 7 August 2008 | Volume 4 | Issue 8 | e1000133T
a
b
l
e
2
.
C
l
a
d
e
s
o
f
A
/
H
1
N
1
(
A
–
H
,
F
i
g
u
r
e
1
)
a
n
d
A
/
H
3
N
2
(
a
,
b
,
s
1
,
s
2
,
s
3
,
s
4
)
i
n
f
l
u
e
n
z
a
v
i
r
u
s
t
h
a
t
c
o
-
c
i
r
c
u
l
a
t
e
a
m
o
n
g
m
u
l
t
i
p
l
e
l
o
c
a
l
i
t
i
e
s
b
y
e
p
i
d
e
m
i
c
w
e
e
k
.
E
p
i
d
e
m
i
c
W
e
e
k
u
W
1
2
3
4
5
6
7
8
9
1
0
1
1
1
2
1
3
1
4
1
5
T
O
T
A
L
P
o
r
t
l
a
n
d
,
O
R
1
2
2
D
a
a
a
a
D
a
S
e
a
t
t
l
e
,
W
A
1
2
2
a
a
a
L
o
s
A
n
g
e
l
e
s
,
C
A
1
1
8
B
s
1
B
A
B
A
F
a
A
B
F
a
A
B
a
b
A
B
F
a
b
s
1
D
e
n
v
e
r
,
C
O
1
0
5
a
s
2
G
A
A
a
A
a
A
a
A
B
a
A
B
G
a
s
2
O
k
l
a
h
o
m
a
C
i
t
y
,
O
K
9
7
A
D
A
A
D
H
o
u
s
t
o
n
,
T
X
9
5
D
A
E
A
C
A
C
D
F
A
C
D
A
C
a
A
E
a
b
A
B
E
a
A
A
B
C
D
E
F
a
b
K
a
n
s
a
s
C
i
t
y
,
M
O
9
4
A
D
A
A
B
A
A
B
D
D
u
n
l
a
p
,
I
L
8
9
D
D
D
y
e
r
s
b
u
r
g
,
T
N
8
9
F
A
A
F
P
e
k
i
n
,
I
L
8
9
A
B
B
A
A
B
A
b
e
r
d
e
e
n
,
M
S
8
8
A
A
D
A
A
F
A
A
A
D
F
C
h
i
c
a
g
o
,
I
L
8
7
A
A
a
A
A
A
A
B
a
b
A
B
a
a
A
B
a
b
H
o
p
k
i
n
s
v
i
l
l
e
,
K
Y
8
7
D
A
A
B
D
a
A
A
D
b
B
D
B
A
B
D
a
b
B
i
r
m
i
n
g
h
a
m
,
A
L
8
6
a
A
A
a
M
a
d
i
s
o
n
,
A
L
8
6
b
b
N
a
s
h
v
i
l
l
e
,
T
N
8
6
D
D
T
u
l
l
a
h
o
m
a
,
T
N
8
6
A
D
B
D
B
D
D
A
B
D
C
i
n
c
i
n
n
a
t
i
,
O
H
8
4
A
A
A
B
A
B
a
A
C
A
C
A
A
A
C
F
A
B
C
F
a
D
e
t
r
o
i
t
,
M
I
8
3
B
B
K
n
o
x
v
i
l
l
e
,
T
N
8
3
A
A
A
A
D
A
D
A
D
T
o
l
e
d
o
,
O
H
8
3
B
B
W
a
s
h
i
n
g
t
o
n
,
O
H
8
3
A
B
A
B
A
B
A
a
A
A
B
a
T
a
m
p
a
,
F
L
8
2
A
a
D
D
A
A
D
a
A
A
D
a
W
e
b
e
r
C
i
t
y
,
V
A
8
2
A
A
A
B
A
B
A
k
r
o
n
,
O
H
8
1
a
A
A
a
C
l
e
v
e
l
a
n
d
,
O
H
8
1
B
A
A
B
W
i
n
s
t
o
n
-
S
a
l
e
m
,
N
C
8
0
B
B
G
r
a
h
a
m
,
N
C
7
9
B
A
A
B
R
i
c
h
m
o
n
d
,
V
A
7
7
A
B
A
A
A
A
a
A
A
B
a
W
a
s
h
i
n
g
t
o
n
,
D
C
7
7
a
a
A
l
b
a
n
y
,
N
Y
7
3
A
A
D
D
A
a
A
a
A
A
D
a
N
e
w
Y
o
r
k
C
i
t
y
,
N
Y
7
3
a
A
A
H
B
H
B
b
a
a
s
3
s
4
A
B
H
a
b
s
3
s
4
T
O
T
A
L
A
A
B
D
A
B
A
A
B
E
A
B
D
F
a
A
B
C
D
G
A
B
C
D
A
B
C
D
F
H
a
A
B
C
D
H
a
A
B
C
D
F
a
b
A
B
D
E
F
a
b
A
B
D
E
A
a
s
2
a
s
1
a
b
s
3
s
4
L
o
c
a
l
i
t
i
e
s
l
i
s
t
e
d
b
y
l
o
n
g
i
t
u
d
i
n
a
l
o
r
d
i
n
a
t
e
s
(
u
W
)
f
r
o
m
w
e
s
t
t
o
e
a
s
t
.
T
h
e
t
o
t
a
l
n
u
m
b
e
r
o
f
c
l
a
d
e
s
t
h
a
t
c
o
-
c
i
r
c
u
l
a
t
e
i
n
a
g
i
v
e
n
l
o
c
a
l
i
t
y
o
v
e
r
t
h
e
e
n
t
i
r
e
t
i
m
e
p
e
r
i
o
d
l
i
s
t
e
d
i
n
t
h
e
f
a
r
r
i
g
h
t
c
o
l
u
m
n
.
W
e
e
k
1
b
e
g
i
n
s
1
2
/
3
/
2
0
0
6
;
w
e
e
k
2
–
1
2
/
1
0
/
0
6
;
w
e
e
k
3
–
1
2
/
1
7
/
0
6
;
w
e
e
k
4
–
1
2
/
2
4
/
0
6
;
w
e
e
k
5
–
1
2
/
3
1
/
0
6
;
w
e
e
k
6
–
1
/
7
/
2
0
0
7
;
w
e
e
k
7
–
1
/
1
4
/
0
7
;
w
e
e
k
8
–
1
/
2
1
/
0
7
;
w
e
e
k
9
–
1
/
2
8
/
0
7
;
w
e
e
k
1
0
–
2
/
4
/
0
7
;
w
e
e
k
1
1
–
2
/
1
1
/
0
7
;
w
e
e
k
1
2
–
2
/
1
8
/
0
7
;
w
e
e
k
1
3
–
2
/
2
5
/
0
7
;
w
e
e
k
1
4
–
3
/
4
/
0
7
;
w
e
e
k
1
5
–
3
/
1
1
/
0
7
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
p
a
t
.
1
0
0
0
1
3
3
.
t
0
0
2
Molecular Epidemiology of Influenza Virus
PLoS Pathogens | www.plospathogens.org 8 August 2008 | Volume 4 | Issue 8 | e1000133Substantial antigenic diversity was also observed during the
2006–2007 season in the US, as at least five antigenically distinct
types of influenza A virus co-circulated: three antigenically distinct
variants of A/H1N1 viruses (A/New Caledonia/20/1999-like, A/
Solomon Islands/3/2006-like, and A/Brisbane/59/2007-like),
and at least two antigenically different types of A/H3N2 virus
(A/Wisconsin/67/2005-like and A/Brisbane/10/2007-like), while
clade b and isolate s4 also may represent additional antigenic
variants of A/H3N2 virus (Table 4). However, analyses based on
hemagglutinin-inhibition (HI) tests are required to confirm the
antigenic status of these viruses.
Although A/Solomon Islands/3/2006-like viruses and A/
Brisbane/59/2007-like A/H1N1 viruses were represented only
by minor clades during the 2006–2007 season (H and F,
respectively), Solomon Islands-like viruses achieved global A/
H1N1 dominance by the start of the 2007–2008 season, and the
reassortant clade of Brisbane-like viruses rose to dominance later
during the 2007–2008 season [39]. Given that the antigenic
evolution of A/H1N1 influenza virus is thought to be slower than
the A/H3N2 virus, as reflected by eight consecutive years of
dominance by A/New Caledonia/20/1999-like viruses, the rapid
emergence of two new antigenic variants of A/H1N1 virus in a
single year was particularly notable ([30], for example).
The extensive genetic diversity present in both A/H1N1 and A/
H3N2 viruses suggests that multiple introductions of virus have
taken place during the 2006–2007 season, particularly as our
method of collecting viruses clearly underrepresented areas that
are major ports of international travel. As a case in point, further
sampling in the Los Angeles and New York City regions, where
our study still detected significant diversity even at very low
sampling levels, would likely augment the total number of viral
lineages detected, including those imported from South-East Asia.
By sampling in both metropolitan and relatively isolated areas, our
study yielded important information on the geographic distribu-
tion of viral genetic variation: namely, that extensive viral
diversity, including multiple antigenically distinguishable lineages,
disseminated widely across the entire United States during the
epidemic, even into relatively remote areas, so that it was not
confined to the major cities where the virus is thought to enter. As
a particular case in point, even relatively low-density areas or those
A/New Caledonia/20/1999(H1N1)
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Figure 5. Number of amino acid changes along main branches of the tree depicting the phylogenetic relationships between the HA
gene segments from A/H1N1 influenza viruses (adapted from Figure 1 with branches within clades collapsed). The first number
represents total number of amino acid changes, with the number following comma referring to the number of amino acid changes occurring in
antigenic or potential glycosylation sites. The number in parentheses next to the clade label represents the total number of amino acid changes and
those changes at antigenic sites between that clade and the A/New Caledonia/20/1999 vaccine component used from 2000–2001 to 2006–2007.
doi:10.1371/journal.ppat.1000133.g005
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Kentucky (population size ,30,000), harbor significant amounts
of both genetic and antigenic diversity, suggesting that influenza
viruses of multiple antigenic (and other phenotypic) types
extensively infiltrate the United States over the course of a single
season. However, it is important to note that our analyses cannot
exclude that a single co-infected individual could have introduced
multiple clades of influenza virus into the United States, as the
frequency of co-infection among patients in this study is unknown
and represents a key area for further research.
Importantly, it is also possible that the 2006–2007 US epidemic
was particularly difficult to reconstruct due to the unusual
complexity of its evolutionary dynamics, which likely relates to
the incomplete dominance of either the A/H1N1 or A/H3N2
subtype. The dynamics of influenza virus epidemics vary greatly
on an annual basis, and influenza epidemics that are dominated by
the A/H3N2 virus have been associated with higher disease
transmission and more rapid spread than milder A/H1N1-
dominated seasons, as well as stronger synchrony in timing across
the United States [9]. Hence, epidemics that are dominated by a
single A/H3N2 clade (such as the 2004–2005 season [18]) may
exhibit stronger signals of spatial spread, and repeating this
sampling effort during an A/H3N2-dominated influenza season
potentially could yield a stronger spatial pattern. A sampling
scheme that minimizes geographical biases and maximizes the
number of samples collected early in the epidemic also could
increase the likelihood of obtaining a stronger spatial signal.
Additional sequencing of influenza viruses in areas outside the
United States is also essential to understand the global context of
the diversity that enters the US during a given epidemic. From
this, and previous studies [18,21], it is clear that influenza A virus
is introduced into the United States multiple times during an
epidemic. However, the availability of global sequences, particu-
larly at the genomic scale, is currently inadequate to draw any
conclusions about the geographic origins of each viral introduc-
tion. It has been suggested that US epidemics originate more
frequently in California than other states, due to high inter-
connectivity with Asia and Australia [9], but further whole-
genome sequencing of viruses from Asia is clearly needed to test
this hypothesis. Although the tendency of US epidemics to
originate in the relatively warm state of California suggests that
human movements are more important than climatic factors in the
seasonal onset of influenza virus epidemics, further documentation
of the complex spatial-temporal dissemination of the virus over an
Table 3. Number of amino acid differences in the HA gene segment between clades A–H of A/H1N1 influenza virus sampled from
the 2006–2007 US season.
A B C D E NC99 ‘01 ‘02/03 ‘05 F G H SI06
A- 2 2
3 3
4 33
5 22 311
36 15
36 13
1223 12
123
B2 - 4
3 3
4 33
5 22 311
36 15
36 11
1223 12
123
C2
3 4
3 -5
34 5
3 5
35 4
3 4
3 5
3 9
6 15
6 13
122 12
12
D3
4 3
4 5
34 -4
4 4
45 3
4 3
4 4
4 12
346 15
346 14
12234 13
1234
E3 3 5
3 4
4 -4
5 33 412
36 16
36 14
1223 13
123
NC99 3
5 3
5 5
35 4
45 4
5 -1
5 1
5 4
5 10
356 14
356 12
12235 11
1235
‘01 2 2 4
3 3
4 31
5 -0 3 9
36 13
36 11
1223 10
123
‘02/03 2 2 4
3 3
4 31
5 0- 39
36 13
36 11
1223 10
123
‘05 3 3 5
3 4
4 44
5 33 - 12
36 16
36 14
1223 13
123
F 11
36 11
36 9
6 12
346 12
36 10
356 9
36 9
36 12
36 -9
6 8
1226 7
126
G 15
36 15
36 15
6 15
346 16
36 14
356 13
36 13
36 16
36 9
6 -1 0
1226 7
126
H 13
1223 11
1223 13
1223 14
12234 14
1223 12
12235 11
1223 11
1223 14
1223 8
1226 10
1226 -3
2
SI06 12
123 12
123 12
123 13
1234 13
123 11
1235 10
123 10
123 13
123 7
126 7
126 3
2 -
As a comparison, isolates used as the A/H1N1 component of the influenza vaccine in 2006–2007 (A/New Caledonia/20/1999(H1N1) (NC99)) and 2007–2008 (A/Solomon
Islands/3/2006(H1N1) (SI06)) are included, as well as representative isolates from the 2001 (‘01), 2002–2003 (‘02/03) and 2005 (‘05) seasons. Amino acid differences
between clades in set 1 (clades A, B, C, D, E, NC99, ‘01, ‘02/03, and ‘05) and clades in set 2 (clades F, G, H, and SI06) are in bold. Amino acid changes in antigenic sites are
denoted by superscripts as follows:
1–Cb antigenic site;
2–potential glycosylation site;
3–Ca2 antigenic site;
4–Sa antigenic site;
5–Ca1 antigenic site;
6–Sb antigenic site.
For a complete list of amino acid changes at specific sites, see Table S1.
doi:10.1371/journal.ppat.1000133.t003
Table 4. Summary of antigenic characterizations (based on
phylogeny and amino acid comparisons with influenza A
vaccine strains) and adamantane sensitivity (S31N) of all A/
H1N1 and A/H3N2 clades detected in the United States during
the 2006–2007 epidemic.
Clade Subtype Antigenic characterization
Adamantane
sensitivity
A A/H1N1 A/New Caledonia/20/1999-like Sensitive
B A/H1N1 A/New Caledonia/20/1999-like Sensitive
C A/H1N1 A/New Caledonia/20/1999-like Sensitive
D A/H1N1 A/New Caledonia/20/1999-like Sensitive
E A/H1N1 A/New Caledonia/20/1999-like Sensitive
F A/H1N1 A/Brisbane/59/2007-like Sensitive
G A/H1N1 A/Brisbane/59/2007-like Resistant
H A/H1N1 A/Solomon Islands/3/2006-like Sensitive
a A/H3N2 A/Brisbane/10/2007-like Resistant
b A/H3N2 Unknown Sensitive
s1,s2,s3 A/H3N2 A/Wisconsin/67/2005-like Resistant
s4 A/H3N2 Unknown Sensitive
Antigenic characterizations inferred from phylogenetic relationships and
differences in amino acids in antigenic sites of HA.
doi:10.1371/journal.ppat.1000133.t004
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Additionally, the extent of viral and antigenic diversity and the
frequent circulation of minor clades that is detected by intensified
surveillance efforts, such as the present study, suggest that much
more diversity circulates at a global scale than is identified by
routine surveillance. In particular, early detection of minor clades,
particularly in the source populations of East and South-East Asia
[21], could improve recognition of emerging lineages and
prediction of future dominant strains for vaccine design. Indeed,
the antigenically variant A/Brisbane/59/2007(H1N1)-like reas-
sortant clade F detected in this study may not have been picked up
by routine global surveillance until later, as no other publicly
available global isolates from 2006 were found within this clade.
Our findings also suggest that the genetic diversity of the A/
H3N2 virus is substantial even when A/H3N2 is not the dominant
subtype, as was the case for most of the 2006–2007 epidemic. A
major clade (a), a minor clade (b), a reassortant singleton (s4), and
three singletons (s1, s2, s3) that appear to be descendents of the N-
lineage [36] all co-circulated during this epidemic. All these clades
differed in numerous amino acids in the HA, including those in
antigenic and positively selected sites [37]. Both clades a and b, as
well as the s4 singleton, were involved in at least three separate
reassortment events: (a) clade b and singleton s4 (PB1 and M
segments), (b) clades a and b (NP segment), and (c) singleton s4
only (PA, HA, and NA). As a caveat, because our study does not
involve plaque-purified viruses, it is theoretically possible that the
amplification of segments from different viruses co-infecting a
single patient could produce a false signal for reassortment,
particularly for those putative reassortment events that involve a
single virus (for example, the s4 singleton). However, even with this
potential source of bias, the frequency of definitive reassortment
events among A/H3N2 clades is striking, especially compared to
the single reassortment event observed among the A/H1N1
viruses that dominated this season. This most likely reflects the
usually lower prevalence of A/H1N1, which in turn means a
reduced likelihood of mixed infection and hence reassortment. In
addition, given the importance of other geographical regions,
particularly South-East Asia, in the evolution of the influenza A
A/New York/204/2003 A/New York/196/2003
A/New York/198/2003
A/New York/203/2003
A/New York/199/2003
A/New York/201/2003 A/New York/485/2003
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A/Western Australia/58/2004
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Figure 6. Phylogenetic relationships of the HA gene segment of 69 A/H3N2 influenza viruses sampled from the US during the
2006–2007 influenza season, 104 background global A/H3N2 viruses sampled from 2003–2006, and the A/H3N2 component of the
influenza vaccines from the 2006–2007 and 2007–2008 seasons (A/Wisconsin/67/2005) and the component selected for the 2008–
2009 influenza vaccine (A/Brisbane/10/2007). Isolates that are adamantane sensitive (have a serine at position 31 of the M2 gene) are shaded in
blue, while isolates that are resistant to adamantane are shaded in red. Clades of related viral isolates are denoted by rectangles. Clades from the
2006–2007 US epidemic are labeled as follows: major clade (a), minor clade (b), and four singleton isolates (s1, s2, s3, and s4). Clades from previous
global epidemics include the ‘N-lineage’ (adamantane-resistant isolates from 2005–2006). The A/Wisconsin/67/2005 vaccine strain, contained within
the N-lineage, is shaded in olive, and the A/Brisbane/10/2007 vaccine strain, contained within clade a, is shaded in yellow. Bootstrap values (.70%)
are shown for key nodes. The tree is mid-point rooted for purposes of clarity only, and all horizontal branch lengths are drawn to scale.
doi:10.1371/journal.ppat.1000133.g006
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subtype in Canada and Europe during this season [33], the A/
H3N2 virus likely circulated at higher levels outside the US,
providing greater opportunity for reassortment. Of further interest
is why inter-subtype reassortment between A/H1N1 and A/H3N2
viruses is not observed more commonly, despite the apparent co-
circulation of both subtypes over both time and space (Table 2). In
this case, it is possible that a virus produced by inter-subtype
reassortment has a lower fitness, because the greater genetic
distance between the A/H1N1 and A/H3N2 subtypes means that
reassortment events are more likely to disrupt essential functional
interactions among segments.
Finally, the existence of the adamantane-sensitive clade b (A/
H3N2) during this epidemic was surprising, given that global
resistance to adamantanes among influenza A/H3N2 viruses has
increased dramatically in recent years, with more than 95% of A/
H3N2 influenza viruses classified as resistant in the previous 2005–
2006 season in the US [32]. Even more striking was that most of
the genome of clade b isolates was more closely related to the
adamantane-resistant clade a than to older adamantane-sensitive
clades, indicating that this clade did not evolve directly from
adamantane-sensitive viruses as may have been presumed. Rather,
clade b viruses re-acquired sensitivity to adamantane by acquiring
two segments (PB1 and M) from older adamantane-sensitive
viruses through reassortment. This finding supports prior conclu-
sions that sensitivity and resistance to adamantane can be acquired
through genomic reassortment, rather than by direct selection on
the M2 gene for drug resistant mutations [36].
Methods
Phylogenetic analysis of influenza A viruses from the
2006–2007 US epidemic
All viruses were collected as part of a larger 2006–2007 US
surveillance effort conducted by Surveillance Data Inc., in which a
total of 610 influenza virus specimens of both type A and type B
were obtained from nasal and nasopharyngeal swabs from patients
seen with influenza-like illness. At the time of this study, 353 type
A influenza virus genomes had been sequenced and were available
for study. Fifty-six participating physicians, primarily located at
family practices, were recruited from 21 states that were
geographically distributed across the US (AL, CA, CO, FL, IL,
KS, KY, MI, MS, NJ, NY, NC, OH, OK, OR, PA, TN, TX, VT,
VA, WA). Doctors swabbed all patients $ one year of age who
presented with fever and upper respiratory symptoms from
December 1, 2006 to April 1, 2007. An in-office immunoassay
rapid test (Quidel QuickVue Influenza A+B Test) was used to
identify positive influenza samples (A or B), and positive swabs
were sent to a reference laboratory in Rochester, New York, to be
typed as AH1N1, A/H3N2, or influenza B, following growth in
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Figure 7. Phylogenetic relationships of the M gene segment of 69 A/H3N2 influenza viruses sampled from the US during the 2006–
2007 influenza season and 104 background global A/H3N2 viruses sampled from 2003–2006. Clades, shading, labeling, and rooting are
the same as in Figure 6.
doi:10.1371/journal.ppat.1000133.g007
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extracted from viruses via automated nucleic acid extraction using
the Roche MagNA Pure instrument and was shipped to the J.
Craig Venter Institute in Rockville, Maryland, for whole virus
sequencing (methods described previously [38]).
A/H1N1 influenza viruses. A total of 284 whole-genome
sequences of A/H1N1 influenza virus sampled from the 2006–
2007 season in the continental United States were used in this
study (Table S2). A/H1N1 influenza viruses were collected from
December 6, 2006 (which we regard as week 1 of the epidemic) to
March 13, 2007, covering 15 weeks of the 2006–2007 epidemic.
Isolates came from 33 localities within 18 US states, many of
which are located within the greater metropolitan areas of larger
cities (,50 miles away, listed in parentheses, when applicable):
Columbiana, AL (Birmingham, AL), Madison, AL; Granada Hills,
CA (Los Angeles, CA), Hacienda Heights, CA (Los Angeles, CA);
Louisville, CO (Denver, CO); St. Petersburg, FL (Tampa, FL);
Dunlap, IL, Naperville, IL (Chicago, IL), Pekin, IL; Overland
Park, KS (Kansas City, MO); Florence, KY (Cincinnati, OH),
Hopkinsville, KY; Royal Oak, MI (Detroit, MI); Aberdeen, MS;
Bronx, NY (New York City, NY); Graham, NC (Durham, NC),
Winston-Salem, NC; Fairfield, OH (Cincinnati, OH), North
Canton, OH (Akron, OH), Oberlin, OH (Cleveland, OH),
Toledo, OH, Washington, OH; Choctaw, OK (Oklahoma City,
OK), Norman, OK (Oklahoma City, OK); Newberg, OR
(Portland, OR); Dyersburg, TN, Knoxville, TN, Lebanon, TN
(Nashville, TN) , Tullahoma, TN; Conroe, TX (Houston, TX);
Richmond, VA, Weber City, VA; Bennington, VT (Albany, NY).
Population sizes and longitudinal positions of these localities were
determined using 2006 US Census data [40].
A/H3N2 influenza viruses. As A/H1N1 was dominant for
most of the 2006–2007 US influenza season, fewer whole-genome
sequences of A/H3N2 viruses were available for this study (69
isolates). However, as A/H3N2 replaced A/H1N1 as the
dominant subtype towards the end of the 2006–2007 season in
March, the majority (38/69, 55.1%) of A/H3N2 isolates used in
this study were collected between February 25, 2007–March 10,
2007. These 69 A/H3N2 isolates came from 13 states representing
all six US regions. Within these 13 states, isolates were sampled
from 20 localities (those within the greater metropolitan areas of
larger cities listed in parentheses, when applicable): Columbiana,
AL (Birmingham, AL), Madison, AL; Hacienda Heights, CA (Los
Angeles, CA); Louisville, CO (Denver, CO); St. Petersburg, FL
(Tampa, FL); Bloomingdale, IL (Chicago, IL), Lake Zurich, IL
(Chicago, IL), Naperville, IL (Chicago, IL); Florence, KY
(Cincinnati, OH), Hopkinsville, KY; Bronx, NY (New York
City, NY), Glendale, NY; Akron, OH, Washington, OH;
Newberg, OR (Portland, OR); Conroe, TX (Houston, TX);
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Figure 8. Phylogenetic relationships of the PB1 gene segment of 69 A/H3N2 influenza viruses sampled from the US during the
2006–2007 influenza season and 104 background global A/H3N2 influenza viruses sampled from 2003–2006. Clades, shading,
labeling, and rooting are the same as in Figure 6.
doi:10.1371/journal.ppat.1000133.g008
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Phylogenetic analysis. Genome sequences were
downloaded from the NCBI Influenza Virus Resource [41].
Sequence alignments were manually constructed for the major
coding regions of each of the eight genomic segments for both A/
H1N1 and A/H3N2 viruses (with regions of overlapping reading
frame deleted in the case of M1/2 and NS1/2): PB2 (2,277 nt),
PB1 (2,271 nt), PA (2,148 nt), HA (1,698 nt), NP (1,494 nt), NA
(1,407 nt), M1/2 (979 nt), NS1/2 (835 nt). Phylogenetic trees for
the following A/H1N1 data sets were inferred using the maximum
likelihood method available in PAUP* [42]: (a) each genome
segment from all 284 A/H1N1 viruses available from the 2006–
2007 US season; (b) a representative sub-set of 100 A/H1N1
viruses taken from all eight clades from the 2006–2007 season
(Table S2), along with 48 global background sequences from
2001–2006 (largely from New York State, Australia, and New
Zealand) for each genome segment (Table S3); (c) the sub-sample
of 100 A/H1N1 and 48 global background HA sequences, plus 19
additional global HA sequences from 2006–2007, including the
A/H1N1 isolates selected for the 2006–2007 (A/New Caledonia/
20/1999), 2007–2008 (A/Solomon Islands/3/2006), and 2008–
2009 (A/Brisbane/59/2007) vaccine strains [30,33,34] (total of
167 sequences) (Table S4); and (d) the sub-sample of 100 A/H1N1
NA and 48 global background NA sequences, plus 18 additional
global NA sequences from 2006–2007, including the three
influenza vaccine strains (A/New Caledonia/20/1999, A/
Solomon Islands/3/2006, and A/Brisbane/59/2007) (total of
166 sequences) (Table S5). The only function of the background
sequences was to put the phylogenetic relationships of the US
sequences in a more global context.
For the A/H3N2 viruses, phylogenetic trees were inferred using
the maximum likelihood method available in PAUP* [42] for each
of the eight genome segments from 69 A/H3N2 viruses available
sampled during the 2006–2007 US season (Table S6), and 104
whole genome A/H3N2 influenza viruses sampled globally from
2003–2006 that were studied previously [36] (total of 173 viruses)
(Table S7). In addition, phylogenetic trees were estimated that
included the HA and NA gene segments from the original 69
influenza viruses from 2006–2007 and the 104 viruses from 2003–
2006, as well as HA and NA sequences from the A/H3N2
components of influenza vaccines produced for the 2006–2007/
2007–2008 (A/Wisconsin/67/2005) and 2008–2009 (A/Brisbane/
10/2007) seasons [30,33,34] (total of 175 sequences) (Table S8).
In each case, the best-fit model of nucleotide substitution was
identified by MODELTEST [43] as the general reversible
(GTR+I+C4) model, with the frequency of each substitution type,
proportion of invariant sites (I), and the gamma distribution of
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Figure 9. Phylogenetic relationships of the NP gene segment of 69 A/H3N2 influenza viruses sampled from the US during the 2006–
2007 influenza season and 104 background global A/H3N2 influenza viruses sampled from 2003–2006. Clades, shading, labeling, and
rooting are the same as in Figure 6.
doi:10.1371/journal.ppat.1000133.g009
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from the empirical data (parameter values available upon request).
In all cases tree bisection-reconnection (TBR) branch-swapping
was utilized to determine the globally optimal tree. To assess the
robustness of each node on the phylogenetic tree, a bootstrap
resampling process (1,000 replications) using the neighbor-joining
(NJ) method was used, incorporating the ML substitution model.
Clades of related isolates were identified by high bootstrap values
(.70) and exceptionally long branch lengths.
Amino acid comparisons between clades of A/H1N1 and
A/H3N2 influenza viruses
The parsimony-based MacClade program [44] was used to
determine those amino acid changes in both the HA and NA gene
segments (Table S9) that occurred between each of the eight clades
of A/H1N1 virus from the US, as well as global background viruses
from 2001–2005 and A/H1N1 vaccine strains. Changes were also
identified in potential glycosylation sites, antigenic regions (Sa, Sb,
Cb, Ca1,C a 2) [45], and the receptor-binding site [46]. The
MacClade program also was employed to identify amino acid
changes between clades of A/H3N2 and influenza virus vaccine
strains, including those in antigenic sites and at eighteen sites
previously identified as undergoing positive selection [37].
Supporting Information
Figure S1 Phylogenetic relationships of the PB2 gene segment of
A/H1N1 influenza viruses sampled from the United States during
the 2006–2007 influenza season and globally from 2001–2006,
estimated using an ML method. Colored rectangles (labeled A–H)
represent eight clades of related viral isolates from the 2006–2007
U.S. season that are present on phylogenies for all genome
segments (Figures S1, S2, S3, S4, S5, S6). Clade A represents the
major clade from this season. Global background isolates are
unshaded and labeled by season in red font. Bootstrap values
(.70%) are shown for key nodes. The tree is mid-point rooted for
clarity only, and all horizontal branch lengths are drawn to scale.
Found at: doi:10.1371/journal.ppat.1000133.s001 (0.50 MB EPS)
Figure S2 Phylogenetic relationships of the PA gene segment of
A/H1N1 influenza viruses sampled from the United States during
the 2006–2007 influenza season and globally from 2001–2006,
estimated using an ML method. Color schemes and rooting are
same as in Figure S1.
Found at: doi:10.1371/journal.ppat.1000133.s002 (0.45 MB EPS)
Figure S3 Phylogenetic relationships of the NP gene segment of
A/H1N1 influenza viruses sampled from the United States during
the 2006–2007 influenza season and globally from 2001–2006,
estimated using an ML method. Color schemes and rooting are
same as in Figure S1.
Found at: doi:10.1371/journal.ppat.1000133.s003 (0.49 MB EPS)
Figure S4 Phylogenetic relationships of the NA gene segment of
A/H1N1 influenza viruses sampled from the United States during
the 2006–2007 influenza season and globally from 2001–2006,
estimated using an ML method. Color schemes and rooting are
same as in Figure S1.
Found at: doi:10.1371/journal.ppat.1000133.s004 (0.49 MB EPS)
Figure S5 Phylogenetic relationships of the M gene segment of
A/H1N1 influenza viruses sampled from the United States during
the 2006–2007 influenza season and globally from 2001–2006,
estimated using an ML method. Color schemes and rooting are
same as in Figure S1.
Found at: doi:10.1371/journal.ppat.1000133.s005 (0.44 MB EPS)
Figure S6 Phylogenetic relationships of the NS gene segment of
A/H1N1 influenza viruses sampled from the United States during
the 2006–2007 influenza season and globally from 2001–2006,
estimated using an ML method. Color schemes and rooting are
same as in Figure S1.
Found at: doi:10.1371/journal.ppat.1000133.s006 (0.45 MB EPS)
Figure S7 Phylogenetic relationships of the PB2 gene segment of
69 A/H3N2 influenza viruses sampled from the United States
during the 2006–2007 influenza season and 104 background
global A/H3N2 influenza viruses sampled from 2003–2006.
Isolates that are adamantane sensitive (have a serine at position
31 of the M2 gene) are shaded in blue, while isolates that are
adamantane resistant are shaded in red. Clades of related viral
isolates are denoted by rectangles. Clades from the 2006–2007
U.S. epidemic are labeled as follows: major clade (a), minor clade
(b), and four singleton isolates (s1, s2, s3, and s4). Clades from
previous global epidemics include the ‘N-lineage’ (adamantane-
resistant isolates from 2005–2006). Bootstrap values (.70%) are
shown for key nodes. The tree is mid-point rooted for purposes of
clarity only, and all horizontal branch lengths are drawn to scale.
Found at: doi:10.1371/journal.ppat.1000133.s007 (0.43 MB EPS)
Figure S8 Phylogenetic relationships of the PA gene segment of
69 A/H3N2 influenza A viruses sampled from the United States
during the 2006–2007 influenza season and 104 viruses sampled
globally from 2003–2006. Labeling, color scheme, and rooting are
identical as Figure S7.
Found at: doi:10.1371/journal.ppat.1000133.s008 (0.43 MB EPS)
Figure S9 Phylogenetic relationships of the NA gene segment of
69 A/H3N2 influenza A viruses sampled from the United States
during the 2006–2007 influenza season and 104 viruses sampled
Table 5. Amino acids at variable sites of the HA gene
segment of A/H3N2 influenza viruses from the ‘N-lineage’,
clade a, clade b, and singleton isolates s1, s2, s3, and s4
(Figure 6), with differing amino acids in bold.
HA site N-lineage s1 s2 s3 s4 Clade a Clade b
6 N NNNN N I
4 5 ( C ) S SSSN SS
4 8 ( C ) T TTTI TT
50 (C) G G E GG E G
5 3 ( C )D DDDN DD
112 V V V V I VV
1 4 0 ( A ) K KKKK I K
142 (A*) R G RRR R G
144 (A) N D NNN N N
1 5 7 ( B ) L LLLL L S
173 (D) K K K K E K E
193 (B*) F F F F S FF
199 S S S S P SS
225 N N N N D NN
275 (C*) G G G G D GG
375 N N D N DD D
4 5 0 R RRRR KK
Antigenic sites are specified A–E (listed in parentheses) and sites that have been
identified as undergoing positive selection denoted by an asterisk (
*) [37].
doi:10.1371/journal.ppat.1000133.t005
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identical as Figure S7.
Found at: doi:10.1371/journal.ppat.1000133.s009 (0.47 MB EPS)
Figure S10 Phylogenetic relationships of the NS1/2 gene
segment of 69 A/H3N2 influenza A viruses sampled from the
United States during the 2006–2007 influenza season and 104
viruses sampled globally from 2003–2006. Labeling, color scheme,
and rooting are identical as Figure S7.
Found at: doi:10.1371/journal.ppat.1000133.s010 (0.46 MB EPS)
Table S1 Amino acids at variable sites of the HA gene segment
of A/H1N1 influenza viruses from clades A–H, the A/New
Caledonia/20/1999(H1N1) and A/Solomon Islands/3/
2006(H1N1) vaccine strains, and isolates from 2002/2003 and
2005 (Figure 1), with differing amino acids highlighted in bold.
Antigenic sites Cb, Ca2, Sa, Ca1, Sb and potential glycosylation
sites (Gly) listed in parentheses.
Found at: doi:10.1371/journal.ppat.1000133.s011 (0.10 MB
DOC)
Table S2 Influenza A viruses used in Figures 1–5, and S1, S2,
S3, S4, S5, S6. GenBank accession number, isolate name, subset
membership, clade membership, date of collection, week of
collection, age and sex of patient from whom isolate was collected,
and county in which isolate was assembled for 284 A/H1N1
influenza A viruses collected from December 6, 2006–March 13,
2007 from 19 U.S. states. Subset 1 refers to those isolates included
in the 100-isolate subset sampled from all clades; subset 2 refers to
those isolates included in the 100-isolate subset sampled from the
major clade. Week 1 denotes the first week that isolates in this
study were sampled (week of December 2, 2006). GenBank
accession numbers from the Influenza Virus Resource refer to the
PB2 gene segment (http://www.ncbi.nlm.nih.gov/genomes/
FLU/FLU.html). Clade membership corresponds to the HA
phylogeny (Figure 1).
Found at: doi:10.1371/journal.ppat.1000133.s012 (0.49 MB
DOC)
Table S3 Influenza A viruses used in Figures 1–5, and S1, S2,
S3, S4, S5, S6. GenBank accession numbers, collection dates, and
age and sex of patient from whom isolate were assembled for 48
A/H1N1 influenza viruses sampled globally from 2001–2006.
GenBank accession numbers from the Influenza Virus Resource
refer to the PB2 gene segment (http://www.ncbi.nlm.nih.gov/
genomes/FLU/FLU.html).
Found at: doi:10.1371/journal.ppat.1000133.s013 (0.09 MB
DOC)
Table S4 Influenza A viruses used in Figure 1. GenBank
accession numbers and collection dates for the HA gene segment
of 21 A/H1N1 influenza viruses sampled globally from 2006,
including the A/H1N1 components of the influenza vaccines for
2006–2007 (A/New Caledonia/20.1999), 2007–2008 (A/Solo-
mon Islands/3/2006), and 2008–2009 (A/Brisbane/59/2007).
GenBank accession numbers from the Influenza Virus Resource
refer to the PB2 gene segment (http://www.ncbi.nlm.nih.gov/
genomes/FLU/FLU.html), and accession numbers starting with
ISD are from the Los Alamos National Laboratory’s Influenza
Sequence Database (www.flu.lanl.gov).
Found at: doi:10.1371/journal.ppat.1000133.s014 (0.05 MB
DOC)
Table S5 Influenza A viruses used in Figure S4. GenBank
accession numbers and collection dates for the NA gene of 17 A/
H1N1 influenza viruses sampled globally from 2006, including the
A/H1N1 components of the influenza vaccines for 2006–2007 (A/
New Caledonia/20/1999) and 2007–2008 (A/Solomon Islands/
3/2006). GenBank accession numbers from the Influenza Virus
Resource refer to the NA gene segment (http://www.ncbi.nlm.
nih.gov/genomes/FLU/FLU.html).
Found at: doi:10.1371/journal.ppat.1000133.s015 (0.04 MB
DOC)
Table S6 Influenza A viruses used in Figures 6–9 and Figures
S7, S8, S9, S10. GenBank accession number, isolate name, subset
membership, clade membership, date of collection, week of
collection, age and sex of patient from whom isolate was collected,
and county in which isolate were assembled for 69 A/H3N2
influenza A viruses collected from December 6, 2006–March 14,
2007 from 16 U.S. states. Week 1 denotes the first week that
isolates in this study were sampled (week of December 2, 2006).
GenBank accession numbers from the Influenza Virus Resource
refer to the PB2 gene segment (http://www.ncbi.nlm.nih.gov/
genomes/FLU/FLU.html).
Found at: doi:10.1371/journal.ppat.1000133.s016 (0.16 MB
DOC)
Table S7 Influenza A viruses used in Figures 6–9 and Figures
S7, S8, S9, S10. GenBank accession numbers, collection dates,
and age and sex of patients from whom influenza viruses were
assembled for 104 A/H3N2 influenza viruses sampled globally
from 2003–2006. GenBank accession numbers from the Influenza
Virus Resource refer to the PB2 gene segment (http://www.ncbi.
nlm.nih.gov/genomes/FLU/FLU.html).
Found at: doi:10.1371/journal.ppat.1000133.s017 (0.17 MB
DOC)
Table S8 A/H3N2 influenza viruses used in the 2006–2007/
2007–2008 (A/Wisconsin/67/2005) and 2008–2009 (A/Bris-
bane/10/2007) influenza vaccines, the HA and NA gene segments
of which are included in Figure 6. GenBank accession numbers
from the Influenza Virus Resource refer to the PB2 gene segment
(http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html).
Found at: doi:10.1371/journal.ppat.1000133.s018 (0.03 MB
DOC)
Table S9 Number of amino acid differences in the NA gene
between clades A–H of A/H1N1 influenza virus from the 2006–
2007 U.S. season. As comparison, isolates used as the H1N1
component of the influenza vaccine in 2006–2007 (A/New
Caledonia/20/1999(H1N1) (NC99)) and 2007–2008 (A/Solomon
Islands/3/2006(H1N1) (SI06)) are included. Amino acid differ-
ences between clades that cluster phylogenetically into set 1 (clades
A–E and NC99) and clades that cluster phylogenetically into set 2
(clades F–H and SI06) are in bold.
Found at: doi:10.1371/journal.ppat.1000133.s019 (0.05 MB
DOC)
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